Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

The objective of the present study was to validate the use of intralesional injection of interleukin-2 (IL-2) in patients with skin and soft-tissue melanoma metastases. A total of 24 patients with AJCC stage III or IV melanoma and single or multiple skin and soft-tissue metastases were included. Int...

Descripción completa

Detalles Bibliográficos
Autores principales: Radny, P, Caroli, U M, Bauer, J, Paul, T, Schlegel, C, Eigentler, T K, Weide, B, Schwarz, M, Garbe, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394422/
https://www.ncbi.nlm.nih.gov/pubmed/14583759
http://dx.doi.org/10.1038/sj.bjc.6601320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394422/
https://www.ncbi.nlm.nih.gov/pubmed/14583759
http://dx.doi.org/10.1038/sj.bjc.6601320

Ejemplares similares